DEF 14A

Company

Wave Life Sciences Ltd.

Filed

June 26, 2023

Period of Report

August 1, 2023

Accession Number

0001193125-23-175031

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →